Abiraterone for the treatment of metastatic prostate cancer without previous chemotherapy

被引：0
|
作者：
Laffman-Johnson, Elise
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2013年 / 93卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：220 / 220
页数：1
相关论文
共 50 条
  • [41] What do we know about treatment sequencing of abiraterone, enzalutamide, and chemotherapy in metastatic castration-resistant prostate cancer?
    Souhil Lebdai
    Victor Basset
    Julien Branchereau
    Alexandre de La Taille
    Vincent Flamand
    Thierry Lebret
    Thibaut Murez
    Yann Neuzillet
    Guillaume Ploussard
    François Audenet
    World Journal of Urology, 2016, 34 : 617 - 624
  • [42] The optimal treatment of metastatic hormone-naive prostate cancer: abiraterone acetate or docetaxel?
    Aoun, Fouad
    El Rassy, Elie
    Sleilaty, Ghassan
    Assi, Tarek
    Bakouny, Ziad
    Kattan, Joseph
    FUTURE ONCOLOGY, 2017, 13 (30) : 2785 - 2790
  • [43] TIME ON TREATMENT WITH ABIRATERONE IN MEN WITH DE NOVO METASTATIC CASTRATION SENSITIVE PROSTATE CANCER
    Stattin, Par
    Garmo, Hans
    Thellenberg-Karlsson, Camilla
    Fallara, Giuseppe
    Styrke, Johan
    Lissbrant, Ingela Franck
    Gedeborg, Rolf
    JOURNAL OF UROLOGY, 2022, 207 (05): : E449 - E449
  • [44] Abiraterone is effective and should be considered for the treatment of metastatic castrate-naive prostate cancer
    Elkon, Jacob M.
    Millett, Ralph L.
    Millado, Kristin F.
    Lin, Jianqing
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (05) : 507 - 509
  • [45] New drugs in the treatment of metastatic castration-resistant prostate cancer: abiraterone acetate
    Martinez-Hernandez, Lucia
    Martinez-Prieto, Marcela
    Galvan-Salazar, Gabriel
    GACETA MEXICANA DE ONCOLOGIA, 2013, 12 (01): : 32 - 40
  • [46] Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer
    Slovin, Susan F.
    Knudsen, Karen
    Halabi, Susan
    de Leeuw, Renee
    Shafi, Ayesha
    Kang, Praneet
    Wolf, Steven
    Luo, Bin
    Gopalan, Anuradha
    Curley, Tracy
    Fleming, Mark
    Molina, Ana
    Fernandez, Celina
    Kelly, Kevin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (32) : 5015 - +
  • [47] Comparative Study on the Effect of Docetaxel and Abiraterone in the Treatment of Metastatic Castration Resistant Prostate Cancer
    Ma, Liming
    Chen, Shaopeng
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 86 : 70 - 77
  • [48] Abiraterone Followed by Enzalutamide Versus Enzalutamide Followed by Abiraterone in Chemotherapy-naive Patients With Metastatic Castration-resistant Prostate Cancer
    Matsubara, Nobuaki
    Yamada, Yoko
    Tabata, Ken-ichi
    Satoh, Takefumi
    Kamiya, Naoto
    Suzuki, Hiroyoshi
    Kawahara, Takashi
    Uemura, Hiroji
    Yano, Akihiro
    Kawakami, Satoru
    Otsuka, Masafumi
    Fukasawa, Satoshi
    CLINICAL GENITOURINARY CANCER, 2018, 16 (02) : 142 - 148
  • [49] The effect of chemotherapy on the exposure-response relation of abiraterone in metastatic castration-resistant prostate cancer
    Boerrigter, Emmy
    Benoist, Guillemette E.
    Overbeek, Joanneke K.
    Donders, Rogier
    Mehra, Niven
    van Oort, Inge M.
    Ter Heine, Rob
    van Erp, Nielka P.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (03) : 1170 - 1178
  • [50] AN EPIDEMIOLOGICAL EVALUATION OF CHEMOTHERAPY USED IN THE TREATMENT OF METASTATIC PROSTATE CANCER
    Chevalier, P.
    Moeremans, K.
    VALUE IN HEALTH, 2011, 14 (07) : A468 - A468
12345